SAN CARLOS, Calif. and BOSTON — Factorial Biotechnologies, an emerging single-cell sequencing company with a novel intracellular library preparation technology, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a new collaboration. Through this partnership, Factorial will leverage Ginkgo Enzyme Services to develop a novel isothermal DNA polymerase for […]

Funds to support further development and commercialization of the Company’s INDUCE-seq DNA break mapping technology Platform technology provides in situ off-target measurement in clinically relevant cells to accelerate the progression of cell and gene therapy programs New investors include Illumina Ventures, Mérieux Equity Partners, and HERAN Partners Cambridge, UK: Broken String Biosciences (“Broken String”), a genomics company […]

Building on GenScript’s fast and dependable in-vitro transcription mRNA synthesis service, GenScript now offers the most comprehensive range of RNA formats critical, enabling fast delivery of complex design for the research and development of RNA vaccines and therapeutics PISCATAWAY, NJ — GenScript Biotech Corporation, the world’s leading provider of life-science research tools and services, has expanded […]

Hong Kong – MGI, a company committed to building core tools and technology to lead life science, today announced the official opening of αLab in the Hong Kong Science & Technology Parks (“HKSTP”), the city’s largest R&D base and one of the most important incubators. Integrating artificial intelligence R&D, application transformation and incubation platform, the brand-new laboratory aims […]

Strengthen cellular analysis with cost-efficient multiomic readouts and streamlined workflows PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the commercial availability of a new kit to expand the capabilities of its Chromium Single Cell Gene Expression Flex assay to include high-throughput multiomic cellular profiling. The […]

Under the new agreement, Integrated DNA Technologies (IDT) will sell Aldevron cGMP-manufactured CRISPR nucleases to enable customers to rapidly transition from discovery to clinic CORALVILLE, Iowa and FARGO, N.D. — Leading CRISPR gene editing companies, Integrated DNA Technologies and Aldevron, inked a new global distribution agreement to expand key CRISPR solutions for cell and gene […]

ERS Genomics & Demeetra Enter Into CRISPR/Cas9 Licensing Agreement Demeetra to broaden synthetic biology and bioprocessing technology through combined CRISPR/Cas9 IP and Demeetra’s own dimeric Cas-CLOVER. Dublin, Ireland and Kentucky, USA, September 12: ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with Demeetra AgBio (‘Demeetra’). This is a non-exclusive licensing agreement […]

As a part of the National Institute of Standards and Technology (NIST) Genome Editing Consortium, BioSkryb will help enable increased confidence in gene edited research and commercial products DURHAM, N.C. – BioSkryb Genomics, a company transforming single-cell analysis by enabling the most complete multiomic view of the cellular ecosystem, from discovery to diagnostics, today announced […]

COLOGNE, Germany — Singleron has announced the launch of its AccuraCode® TCR library construction kit for high-throughput T-cell receptor (TCR) profiling. It enables simultaneous analysis of hundreds of samples for T cell clonotypes, gene usage, V(D)J recombination patterns, and diversity, all supported by compatible bioinformatics pipelines. The product is built upon Singleron’s molecular barcoding technology, enabling multiplexing […]

The SOPHiA DDM™ Platform will help Laboratorio Curie advance its research into BRCA gene mutations BOSTON and ROLLE, Switzerland — Sophia Genetics (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, has expanded its relationship with Laboratorio Curie, a leading laboratory located in the capital city of Paraguay. Laboratorio Curie is now live on the SOPHiA DDM™ Platform […]